Skip to content

Clinical trials

Completed Diabetic Nephropathies trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Status: Completed Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20101
20111
20121
20132
20141
20152
20181
20191
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Boehringer Ingelheim2
Pfizer2
AstraZeneca1
Baker Heart and Diabetes Institute1
CSL Behring1
Dimerix Bioscience Pty Ltd1
Gilead Sciences1
Janssen Research & Development, LLC1
Keryx Biopharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies18
Diabetes Mellitus, Type 28
Renal Insufficiency, Chronic6
Kidney Diseases4
Albuminuria3
Glomerulonephritis2
Diabetes Mellitus1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Glomerulosclerosis, Focal Segmental1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.